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Abstract___A radical cascade involving 6-endo cyclization of aryl radicals generated from 
N-acryloyl-N-(1-methylethenyl)-9-bromophenanthren-10-ylmethylamines, followed by 
5-endo-trig cyclization of the resulting α-amidoyl radicals afforded phenanthroindolizidines 
bearing a methyl substituent at the angular C13a position.  2,3,6-Trimethoxy derivative was 
synthesized by using this method, but its spectral data were not in accord with those of 
literature values reported for hypoestestatin 1.  Further synthetic study towards hypoestestatin 
1 is demonstrated.   
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1.  Introduction 
Radical cascade cyclization is recognized as a powerful tool for the construction of polycyclic 
compounds, including natural products.1  We recently reported that Bu3SnH-mediated radical 
cyclization of N-methacryloyl bromoenamine 1a gave the tricyclic compound 4a together with 
tetrahydroisoquiloline 5a.2  Formation of 4a from 1a can be explained in terms of a radical 
cascade that involves 6-endo cyclization of aryl radical 2a and successive 5-endo cyclization of 
the resulting α−amidoyl radical 3a.  Compound 5a might be a so-called reduction product 
derived from 3a.  We also reported that N-acryloyl enamine 1b gave no corresponding radical 
cascade product 4b but afforded only compound 5b.  These results indicated that the methyl 
substituent at the α-position of α,β-unsaturated amide acted as an effective radical-stabilizing 
group for the cyclization of α-amidoyl radical 3a.  We have now found that the introduction of 
a methyl substitutent onto the alkenic bond of enamide (such as 6) also gives the radical 
cascade product.  In this paper, we describe the results in this area together with an 
application of this method to the synthesis of a phenanthroindolizidine skeleton bearing a 
methyl substituent at the angular position.  
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2.  Results and discussion 
2.1. Attempt to synthesize hypoestestatin 1 
The compound 6 having a methyl substituent on the alkenic bond of enamide was treated with 
Bu3SnH in the presence of azobis(cyclohexanecarbonitrile) (ACN) in boiling toluene to give 
the radical cascade product 8 in 22% yield (Scheme 2).  As mentioned above, the compound 
1b having no methyl substituent on the alkenic bond of enamide gave no radical cascade 
product 4b by the cyclization of 3b.2  The successful formation of 8 from 6 was probably 
because the presence of a methyl substituent on the radical center of α-amidoyl radical 7 
retarded the intermolecular reduction with Bu3SnH more effectively than the radical 3b.  
















Scheme 2.  
 
We then applied this method to the synthesis of phenanthroindolizidines3 bearing a methyl 
substituent at angular position.  Hypoestestatin 1 (9) is one such compound that was isolated 
from the extract of the East African shrub Hypoëstes verticillaris by Pettit’s group4 and was 
found to markedly inhibit the growth of the murine P-388 cell line.  There has been no report 
in the literature on the synthesis of hypoestestatin 1.  Our retrosynthetic analysis of 
hypoestestatin 1 involved 6-endo/5-endo radical cascade cyclization of enamide 11 followed by 





















Scheme 3.  
 
A radical precursor 11 was prepared as shown in Scheme 4.  The Perkin reaction5 of 
potassium p-methoxyphenylacetate and 2-bromo-4,5-dimethoxybenzaldehyde gave carboxylic 
acid 12, whose esterification gave the corresponding methyl ester 13.  Radical cyclization of 
136 followed by reduction of the ester group with LiAlH4 gave known phenanthrenyl methanol 
14.7  Treatment of 14 with NBS in CH2Cl2 afforded bromo alcohol 15, which was converted 
to the secondary amine 17 by treatment with Ph3P and CBr4 and successive condensation of the 
resulting allyl bromide with amine 16.8  Treatment of 17 with acryloyl chloride gave 
α,β-unsaturated amide 18, whose oxidation with MCPBA and thermal elimination of the 
resulting sulfoxide in the presence of sodium hydrogen carbonate in boiling xylene gave 11.  
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The radical cyclization of 11 with Bu3SnH in the presence of ACN gave lactam 10 in 39% 
yield (Scheme 5).  Lactam 10 was reduced with LiAlH4 to give the target molecule 9. 
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1H and 13C NMR spectra of 9, however, were not in accord with those of hypoestestatin 1 
reported by Pettit et al.  In the 1H NMR spectrum of compound 9 in CD3OD, the signal due to 
the angular methyl group appeared as a singlet at δ 1.07, whereas the corresponding signal 
reported for hypoestestatin 1 was shifted to a lower field at δ 1.30.  Its lower field shift was 
presumed to be a result of the formation of the quaternary ammonium salt.  Hence, we turned 
our attention to the 1H NMR spectra of carbonate salt derived from compound 9.  In the event, 
the signal due to the methyl protons of carbonate salt of 9 was shifted to a lower field at δ 1.27, 
but the other signals were not in accord with those reported for hypoestestatin 1.  Therefore, it 
was thought that compound 9 was not hypoestestatin 1. 
 
2.2. Attempt to synthesize another possible structure of hypoestestatin 1 
We speculated the correct structure of hypestestatin 1 to be 32 in which three methoxy groups 
occupied 3, 6 and 7 positions on the phenanthroindolizidine ring.  Our attention was then 
turned to the synthesis of 32 by radical cascade cyclization of compound 30 (Scheme 8).  The 
synthesis of compound 30 was begun by Perkin reaction of 
2-bromo-4,5-dimethoxyphenylacetic acid9 and p-anisaldehyde followed by esterification to 
give 19 (Scheme 6).  A subsequent radical cyclization of 19 in toluene gave the known 
phenanthrene ester 2010 in 43% yield.  The low yield of 20 might be ascribed to the formation 
of dehydro congener of 20 as a result that toluene acted as a hydrogen source.  So, we then 
turned our attention to the use of chlorobenzene as a solvent for the radical cyclization of 19 to 








































Reduction of 20 with LiAlH4 gave alcohol 21.  However, treatment of 21 with NBS or Br2 
under various conditions afforded no brominated compound 22.  A substitution pattern of the 
methoxy groups on the phenanthrene ring probably caused a reduction of relative electron 
density at the C-9 position of 21 as compared to compound 14.   
We therefore tried to introduce a bromine atom at the desired position through an 
ortho-lithiation of amide.11  N-tert-Butylmethyl amide 23 was chosen as a substrate for the 
ortho-lithiation reaction, since the tert-butylmethyl amide group has higher direction ability for 
ortho-lithiation and is known to be hydrolyzed more easily than other tertiary amides such as 
diethylamide.12  Lithiation of compound 23 with sec-BuLi in the presence of 
tetramethylethylenediamine (TMEDA) at -94 °C to -78 °C followed by bromination with CBr4 
gave the desired bromide 24.  Deprotection of the tert-butyl group of 24 with trifluoroacetic 
acid afforded secondary amide 25.  Subsequent hydrolysis of 25, however, did not proceed 
under several conventional conditions, probably because of steric hindrance of a neighboring 
bromine.  Therefore, we explored another functional group transformation of 25: that is, 
hydride was used for the nucleophile instead of sterically more demanding hydroxide ion.  It 
was found that a combination of DIBAL and Schwartz reagent13 reduced secondary amide 25 
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The method for the synthesis of the target compound 32 from aldehyde 27 is shown in Scheme 
8.  Reductive amination of aldehyde 27 with primary amine 16 afforded the secondary amine 
28, which was converted to the radical precursor 30 via compound 29 by a similar sequence of 
reactions of 17 giving 11 (see Scheme 4).  The radical cascade of 30 involving 6-endo/5-endo 
cyclizations proceeded successfully to give lactam 31.  The subsequent reduction of 31 with 
LiAlH4 gave the target compound 32.  However, unfortunately, the 1H NMR spectral data of 
32 were again not in accord with those of hypoestestatin 1 reported by Pettit et al.  In the 1H 
NMR spectrum, the signal due to the angular methyl group of 32 appeared as a singlet at δ 1.07 
in CD3OD, whereas the corresponding signal of carbonate salt of 32 was shifted to a lower 
field at δ 1.22 ppm.  However, the other signals of carbonate salt of 32 were not in accord 
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Scheme 8.    
3. Conclusion 
We accomplished the synthesis of 2,3,6-trimethoxy phenanthroindolizidine 9 and 
3,6,7-trimethoxy isomer 32 by 6-endo/5-endo radical cascade cyclization of the 
corresponding bromo enamide 11 and 30, respectively.  Although 1H NMR spectral 
data of the resulting 9 and 32 were not in accord with those of reported hypoestestatin 1, 
the present study revealed that a phenanthroindolizidine skeleton bearing a methyl 
substituent at the angular C13a position can be easily constructed by this method.     
 
4. Experimental 
4.1. General  
Melting points are uncorrected.  Infrared (IR) spectra were recorded on a Shimadzu 
FTIR-8100 spectrophotometer for solutions in CHCl3.  1H NMR and 13C NMR spectra 
were measured on a JEOL JNM-EX 270 or a JEOL JNM-GSX 500 spectrometer for 
solutions in CDCl3.  δ Values quoted are relative to tetramethylsilane.  High 
resolution mass spectra (HRMS) were obtained with a JEOL JMS-SX-102A mass 
spectrometer.  Column chromatography was performed on Silica gel 60 N (Kanto 
Kagaku Co., Ltd., spherical, neutral, 63-210 μm) under pressure.  Thin layer 
chromatography was carried out on silica gel Wakogel B-5F.   
4.1.1. (±)-N-Acryloyl-N-(1-methylethenyl)-2-bromobenzylamine (6).  To a solution 
of N-acryloyl-N-[1-methyl-2-(phenylsulfanyl)ethyl]-2-bromobenzylamine, prepared in a 
manner similar to that described for 18 (see Supplementary data), (1.09 g, 2.80 mmol) 
in CH2Cl2 (25 mL) was added dropwise a solution of MCPBA (80%) (604 mg, 2.80 
mmol) in CH2Cl2 (25 mL) at 0 °C.  After stirring at the same temperature for 30 min, 
an aqueous 10% Na2S2O3 solution was added to the reaction mixture and the mixture 
was extracted with CHCl3.  The organic layer was washed with a saturated aqueous 
NaHCO3 solution and brine, dried (MgSO4), and concentrated under a reduced pressure.  
The residue was purified by column chromatography on silica gel (hexane/AcOEt, 3:1) 
to afford N-acryloyl-N-[1-methyl-2-(phenylsulfinyl)ethyl]-2-bromobenzylamine as a 
colorless oil.   
The above sulfoxide (882 mg, 2.17 mmol) was heated in boiling xylene (40 mL) in the 
presence of NaHCO3 (365 mg) for 12 h.  A saturated aqueous NH4Cl solution was 
added to the reaction mixture and the mixture was extracted with AcOEt.  The organic 
layer was washed with brine, dried (MgSO4), and concentrated under a reduced pressure.  
The residue was purified by column chromatography on silica gel (hexane/AcOEt, 10:1
→6:1) to afford 6 (490 mg, 62%, 2 steps) as a colorless oil.  IR (CHCl3) ν 1645, 1615 
cm-1; 1H NMR (270 MHz, CDCl3) δ 1.90 (3H, s), 4.77 (1H, s), 4.89 (2H, s), 5.03 (1H, d, 
J = 1.3 Hz), 5.69 (1H, dd, J = 10.1, 2.1 Hz), 6.45 (1H, dd, J = 16.8, 2.3 Hz), 6.65 (1H, 
dd, J = 16.8, 9.9 Hz), 7.10 (1H, td, J = 7.7, 1.9 Hz), 7.22-7.35 (2H, m), 7.52 (1H, dd, J = 
7.9, 1.0 Hz); 13C NMR (68 MHz, CDCl3) δ 21.2, 48.7, 115.6, 123.2, 127.3, 127.8, 128.0, 
128.5, 129.4, 132.4, 136.2, 143.2, 165.0.  Anal. Calcd for C12H12BrNO: C, 55.73; H, 
5.04; N, 5.00.  Found: C, 55.61; H, 5.04; N, 5.02. 
4.1.2. (±)-1,2,3,5,10,10a-Hexahydro-10a-methylpyrrolo[1,2-b]isoquinolin-3-one (8).  
To a boiling solution of 6 (264.0 mg, 0.94 mmol) in toluene (30 mL) was added 
dropwise a solution of Bu3SnH (0.38 ml, 1.41 mmol) and ACN (46.7 mg, 0.19 mmol) in 
toluene (30 mL) over 2.5 h by employing a syringe-pump technique and the mixture 
was further heated for 10 min.  After removal of solvent, the residue was purified by 
column chromatography on silica gel containing 10% KF (hexane/AcOEt, 3:1→2:1→
1:1→2:3) to afford 8 (41.1 mg, 22%) as a colorless oil.  IR (CHCl3) ν 1670 cm-1; 1H 
NMR (270 MHz, CDCl3) δ 1.23 (3H, s), 1.95-2.15 (2H, m), 2.35-2.65 (2H, m), 2.76 (1 
H, d, J = 15.6 Hz), 2.92 (1 H, d, J = 15.6 Hz), 4.16 (1 H, d, J = 17.6 Hz), 5.02 (1 H, d, J 
= 17.6 Hz), 7.06-7.36 (5 H, m); 13C NMR (68 MHz, CDCl3) δ 23.8, 29.7, 33.1, 40.1, 
41.5, 58.0, 126.4, 126.5, 126.6, 129.6, 131.0, 133.7, 173.4; HRMS calcd for C13H15NO: 
201.1154, found: 201.1154. 
4.1.3. 10-Bromo-9-hydroxymethyl-2,3,6-trimethoxyphenanthrene (15).  To a 
solution of 14 (119.0 mg, 0.399 mmol) in CH2Cl2 (5 mL) was added NBS (78.1 mg, 
0.439 mmol) at room temperature in the dark and the mixture was stirred at the same 
temperature for 3 h.  An aqueous 10% Na2S2O3 solution was added to the reaction 
mixture and the mixture was extracted with CH2Cl2.  The organic layer was washed 
with a saturated aqueous NaHCO3 solution and brine, dried (MgSO4), and concentrated 
under a reduced pressure.  The residue was purified by column chromatography on 
silica gel (CHCl3) to afford 15 (92.0 mg, 61%) as a colorless crystal.  Mp 176-177°C 
(hexane/AcOEt); IR (CHCl3) ν 3020 cm-1; 1H NMR (500 MHz, CDCl3) δ 1.96 (1H, t, J 
= 6.5 Hz), 4.02 (3H, s), 4.07 (3H, s), 4.11 (3H, s), 5.41 (2H, d, J = 6.5 Hz), 7.26 (1H, dd, 
J = 9.0, 2.5 Hz), 7.80 (1H, s), 7.83 (1H, s), 7.84 (1H, d, J =2.5 Hz); 13C NMR (125 MHz, 
CDCl3) δ 55.5, 55.8, 56.0, 63.5, 103.1, 104.6, 109.3, 115.7, 121.9, 125.0, 125.2, 125.6, 
127.1, 130.8, 132.1, 149.5, 149.7, 158.1.  Anal. Calcd for C19H17BrO4: C, 57.31; H, 
4.54.  Found : C, 57.23; H, 4.57.  
4.1.4. (±)- 
10-Bromo-2,3,6-trimethoxy-N-[1-methyl-2-(phenylsulfanyl)ethyl]phenanthren-9-yl
methylamine (17).  To a solution of 15 (151.2 mg, 0.401 mmol) in CH3CN (40 mL) 
were added PPh3 (485.6 mg, 1.84 mmol) and CBr4 (597.0 mg, 1.80 mmol) at room 
temperature and the mixture was stirred at the same temperature for 2 h.  After 
removal of solvent, the residue was purified by column chromatography on silica gel 
(CHCl3) to afford 10-bromo-9-bromomethyl-2,3,6-trimethoxyphenanthrene 
quantitatively.  1H NMR (270 MHz, CDCl3) δ 4.02 (3H, s), 4.08 (3H, s), (3H, s), 5.24 
(2H, s), 7.29 (1H, dd, J = 8.2, 2.3 Hz), 7.79 (1H, s), 7.80 (1H, s), 7.83 (1H, d J = 2.6 
Hz), 8.08 (1 H, d, J = 8.2 Hz).  Due to its lability, it was used in the next step 
immediately. 
To a mixture of 1-methyl-2-(phenylsulfanyl)ethylamine (16) (149.6 mg, 0.89 mmol), 
Na2CO3 (37.2 mg, 0.35 mmol), NaI (37.2 mg, 0.25 mmol) and Et4NI (12.4 mg, 0.05 
mmol) in THF (10 mL)/1,4-dioxane (5 mL) was added dropwise a solution of the above 
bromide (0.401 mmol) in THF (5 mL) at room temperature over 1.5 h and the mixture 
was stirred at the same temperature for 27 h.  The reaction mixture was diluted with 
H2O and the mixture was extracted with AcOEt.  The organic layer was dried 
(MgSO4) and concentrated under a reduced pressure.  The residue was purified by 
column chromatography on silica gel (CHCl3/MeOH, 50:1) to afford 17 (178.2 mg, 
84%) as a yellow oil.  1H NMR (270 MHz, CDCl3) δ 1.33 (3H, d, J = 5.6 Hz), 1.87 
(1H, brs), 2.98-3.13 (3H, m), 4.02 (3H, s), 4.09 (3H, s), 4.12 (3H, s), 4.40 (1H, d, J = 
12.2 Hz), 4.51 (1H, d, J = 12.2 Hz), 7.13-7.33 (6H, m), 7.82 (1H, s), 7.84 (1H, s), 7.85 
(1H, s), 8.14 (1H, d, J = 8.9 Hz); 13C NMR (68 MHz, CDCl3) δ 20.9, 41.7, 49.8, 52.5, 
55.9, 56.4, 56.5, 103.6, 105.0, 110.0, 116.2, 122.4, 125.3, 125.8, 126.5, 127.5, 129.2, 
130.2, 131.3, 132.8, 136.5, 149.8, 150.3, 158.5.  Anal. Calcd for C27H28BrNO3S: C, 
61.59; H, 5.36; N, 2.66.  Found: C, 61.54; H, 5.49 N, 2.64. 
4.1.5. 
N-Acryloyl-10-bromo-N-(1-methylethenyl)-2,3,6-trimethoxyphenanthren-9-ylmeth
ylamine (11).  To a solution of 18 (753 mg, 1.30 mmol) in CH2Cl2 (30 mL) was added 
dropwise a solution of MCPBA (80%) (280 mg, 1.30 mmol) in CH2Cl2 (30 mL) at 0 °C 
and the mixture was stirred at the same temperature for 10 min.  An aqueous 10% 
Na2S2O3 solution was added to the reaction mixture and the mixture was extracted with 
CHCl3.  The organic layer was washed with a saturated aqueous NaHCO3 solution and 
brine, dried (MgSO4), and concentrated under a reduced pressure to give 
N-acryloyl-N-[1-methyl-2-(phenylsulfinyl)ethyl]-10-bromo-2,3,6-trimethoxyphenanthr
en-9-ylmethylamine.  The residue was used in the next step without further 
purification.    
The above sulfoxide was heated in boiling xylene (30 mL) in the presence of NaHCO3 
(218 mg, 2.59 mmol) for 12 h.  To the reaction mixture was added a saturated aqueous 
NH4Cl solution and the mixture was extracted with AcOEt.  The oraganic layer was 
washed with brine, dried (MgSO4), and concentrated under a reduced pressure.  The 
residue was purified by column chromatography on silica gel (hexane/AcOEt, 2:1) to 
afford 11 (459 mg, 75%, 2 steps) as a colorless crystal.  Mp 203 °C (hexane/AcOEt); 
IR (CHCl3) ν 1615 cm-1, 1645 cm-1; 1H NMR (500 MHz, CDCl3) δ 1.76 (3H, s), 4.00 
(3H, s), 4.10 (3H, s), 4.12 (3H, s), 4.30 (1H, s), 4.80 (1H, s), 5.68-5.72 (3H, m), 
6.51-6.58 (2H, m), 7.24 (1H, dd, J = 9.0, 2.5 Hz), 7.86 (1H, d, J = 2.5 Hz), 7.86 (1H, s), 
7.88 (1H, s), 8.18 (1H, d, J = 9.5 Hz); 13C NMR (68 MHz, CDCl3) δ 22.6, 47.2, 55.8, 
56.3, 56.4, 103.6, 105.0, 110.1, 116.1, 117.9, 124.7, 125.5, 126.1, 128.0, 128.5, 128.6, 
129.7, 130.8, 142.2, 150.0, 150.2, 158.5, 164.7.  Anal. Calcd for C24H24BrNO4: C, 




To a boiling solution of 11 (80 mg, 0.17 mmol) in toluene (15 mL) was added dropwise 
a solution of Bu3SnH (0.07 ml, 0.26 mmol) and ACN (8 mg, 0.03 mmol) in toluene (15 
mL) over 2 h by employing a syringe-pump technique.  After removal of solvent, 
AcOEt (20 mL) and an aqueous 8% KF solution (20 mL) were added to the residue and 
the mixture was vigorously stirred at room temperature over night.  The precipitate 
was filtered off and the filtrate was extracted with AcOEt.  The organic layer was 
washed with brine, dried (MgSO4), and concentrated under a reduced pressure.  The 
residue was purified by column chromatography on silica gel (hexane/AcOEt, 1:1→1:3
→AcOEt) to afford 10 (26 mg, 39%) as a colorless crystal.  Mp 222-223 °C (dec) 
(hexane/AcOEt); IR (CHCl3) ν 1675 cm-1; 1H NMR (500 MHz, CDCl3) δ 1.35 (3H, s), 
2.20-2.30 (2H, m), 2.52-2.69 (2H, m), 3.06 (1H, d, J = 16.5 Hz), 3.24 (1H, d, J = 16.0 
Hz), 4.03 (3H, s), 4.07 (3H, s), 4.11 (3H, s), 4.49 (1H, d, J = 16.5 Hz), 5.47 (1H, dd, J = 
17.5, 2.5 Hz), 7.25-7.28 (2H, m), 7.91 (1H, d, J = 6.5 Hz), 7.92 (1H, s), 7.94 (1H, s); 
13C NMR (68 MHz, CDCl3) δ 24.3, 29.9, 33.4, 38.2, 38.6, 55.5, 55.9, 56.1, 57.5, 103.8, 
104.1, 105.0, 115.1, 123.0, 123.3, 123.4, 124.0, 124.4, 126.7, 130.3, 148.7, 149.6, 157.9, 
173.3; HRMS calcd for C24H27NO4: 391.1784, found: 391.1782.  Anal. Calcd for 
C24H27NO4: C, 73.64; H, 6.44; N, 3.58.  Found: C, 73.36; H, 6.44 N, 3.56. 
4.1.7. (±)- 
9,11,12,13,13a,14-Hexahydro-2,3,6-Trimethoxy-13a-methyldibenzo[f,h]pyrrolo[1,2
-b]isoquinoline (9).  To a suspension of LiAlH4 (6 mg, 0.13 mmol) in THF (5 mL) 
was added a solution of 10 (26 mg, 0.07 mmol) in THF (5 mL) at room temperature and 
the mixture was heated at reflux for 2 h.  H2O (0.1 mL) was added to the reaction 
mixture and the precipitate was filtered off through a Celite pad.  The filtrate was 
concentrated in a reduced pressure and the residue was purified by column 
chromatography on silica gel (CHCl3/MeOH, 15:1) to afford 9 (24 mg, 96%) as a 
yellow crystal.  Mp was not determined due to its lability.  1H NMR (500 MHz, 
CDCl3) δ 1.05 (3H, s), 1.90-2.00 (4H, m), 2.88-2.94 (1H, m), 3.00 (2H, s), 3.08-3.14 
(1H, m), 4.01 (3H, s), 4.07 (3H, s), 4.10 (3H, s), 4.11 (1H, d, J = 16.5 Hz), 4.45 (1H, d, 
J = 16.5 Hz), 7.21 (1H, dd, J = 9.2, 2.4 Hz), 7.33 (1H, s), 7.85 (1H, d, J = 9.2 Hz), 7.91 
(1H, d, J = 2.4 Hz), 7.93 (1H, s); 13C NMR (68 MHz, CDCl3) δ 17.8, 20.1, 35.7, 39.3, 
47.0, 50.8, 55.5, 55.9, 56.0, 58.9, 103.9, 104.0, 104.8, 114.9, 123.7, 124.1, 124.2, 124.4, 
124.6, 127.3, 130.0, 148.4, 149.4, 157.5; HRMS calcd for C24H27NO3: 377.1991, 
found: 377.1990. 
4.1.8. 9-Bromo-2,3,6-trimethoxy-N-methylphenanthrene-10-carboxamide (25).  To 
a solution of 23 (738 mg, 1.94 mmol) and TMEDA (0.35 ml, 2.32 mmol) in THF (20 
mL) was added sec-BuLi (1.00 M in cyclohexane/hexane, 2.37 mL, 2.37 mmol) at 
-94 °C and the mixture was slowly warmed to -78 °C.  After the mixture was stirred 
for 1 h, a solution of CBr4 (3.27 g, 9.86 mmol) in THF (5 mL) was added and the 
mixture was slowly warmed to room temperature.  H2O was added to the reaction 
mixture and the mixture was extracted with AcOEt.  The organic layer was washed 
with brine, dried (Na2SO4), and concentrated under a reduced pressure.  The crude 
product was purified by column chromatography on silica gel (hexane/AcOEt, 3:1→
1:1) to afford 
9-bromo-N-tert-butyl-2,3,6-trimethoxy-N-methylphenanthrene-10-carboxamide (24) 
along with a little amount of 23.   
The mixture containing 24 was heated at reflux in TFA (5 mL) for 42 h.  After 
evaporation of TFA, the residue was purified by column chromatography on silica gel 
(hexane/AcOEt, 1:1→1:3→AcOEt) to afford 25 (515 mg, ca. 80%) along with a little 
amount of inseparable by-product.  HRMS calcd for C19H18O4N81Br: 405.0399, found: 
405.0411.  This mixture was used in the next step without further purification:  
4.1.9.  9-Bromo-2,3,6-trimethoxyphenanthrene-10-carbaldehyde (27).  To a 
suspension of 25 containing a little amount of unidentified product (206 mg, 0.51 
mmol) (purity of 25 = ca. 80%) in THF (18 mL) was added DIBAL (0.94 M in hexane, 
0.66 mL, 0.62 mmol) at -20 °C, and the mixture was slowly warmed to room 
temperature.  Cp2Zr(H)Cl (191 mg, 0.74 mmol) was added at -20 °C and the mixture 
was stirred at room temperature for 4 h.  The mixture was filtered off through short 
column on silica gel (AcOEt) and the filtrate was concentrated under a reduced pressure.  
The residue was purified by column chromatography on silica gel (hexane/AcOEt, 3:1
→2:1→1:1→1:3).  The first eluate gave 27 (101 mg, 43%, 3 steps) as a yellow crystal.  
Mp 185.5-186.0 °C (hexane/AcOEt); IR (CHCl3) ν 1680cm-1; 1H NMR (500 MHz, 
CDCl3) δ 4.06 (H, s), 4.07 (3 H, s), 4.10 (3H, s), 7.28 (1H, dd, J = 9.3, 2.4 Hz), 7.78 (1H, 
s), 7.78 (1H, d, J = 2.4 Hz), 8.56 (1H, d, J = 9.3 Hz), 8.72 (1H, s), 10.9 (1H, s); 13C 
NMR (125 MHz, CDCl3) δ 55.5, 55.7, 55.8, 102.6, 103.7, 105.3, 116.3, 123.3, 123.7, 
124.3, 124.6, 130.8, 133.0, 134.0, 149.0, 150.4, 160.9, 196.0.  Anal. Calcd for 
C18H15BrO4: C, 57.62; H, 4.03.  Found: C, 57.25; H, 3.99. 
The second eluate gave the recovered 25 (68 mg) (purity of 25 = ca. 80%).    
4.1.10.  
9,11,12,13,13a,14-Hexahydro-3,6,7-trimethoxy-13a-methyldibenzo[f,h]pyrrolo[1,2-
b]isoquinolin-11-one (31).  To a boiling solution of 30 (39.1 mg, 0.083 mmol) in 
toluene (8 mL) was added dropwise a solution of Bu3SnH (0.04 ml, 0.15 mmol) and 
ACN (4.6 mg, 0.02 mmol) in toluene (8 ml) over 2 h by employing a syringe-pump 
technique and the mixture was further heated for 1 h.  After removal of solvent, the 
residue was purified by column chromatography on silica gel containing 10% KF 
(hexane/AcOEt, 1:1→1:3→AcOEt) to give 31 (11.6 mg, 36%) as a pale yellow crystal.  
Mp 198.0-202.5 °C (dec) (Hexane/AcOEt); IR (CHCl3) ν 1675 cm-1; 1H NMR (500 
MHz, CDCl3) δ 1.25 (3H, s, Me), 2.16 (2H, t, J = 8.0 Hz), 2.52-2.67 (2H, m), 2.86 (1H, 
d, J = 15.6 Hz), 3.23 (1H, d, J = 15.6 Hz), 4.01 (3H, s), 4.02 (3H, s), 4.11 (3H, s), 4.34 
(1H, d, J = 17.1 Hz), 5.24 (1H, d, J = 17.1 Hz), 7.18 (1H, dd, J = 9.2, 2.4 Hz), 7.80 (1H, 
d, J = 9.2 Hz), 7.88 (2H, like s); 13C NMR (68 MHz, CDCl3) δ 24.0, 29.8, 33.2, 37.9, 
38.6, 55.4, 55.9, 55.9, 57.3, 102.7 ,103.8, 104.6, 114.9, 121.1, 123.2, 124.6, 124.6, 




b]isoquinoline (32).  To a solution of 31 (12.2 mg, 0.03 mmol) in THF (2 mL) was 
added LiAlH4 (10.5 mg, 0.28 mmol) at 0 °C and the mixture was heated at reflux for 30 
min.  H2O was added to the reaction mixture at 0 °C and the precipitates were filtered 
off through a Celite pad.  The filtrate was concentrated under a reduced pressure and 
the residue was purified by column chromatography on silica gel (MeOH/AcOEt, 1:4) 
to afford 32 (13.4 mg, quant.) as a pale yellow solid.  Mp was not determined due to its 
lability.  1H NMR (270 MHz, CDCl3) δ 1.02 (3H, s), 1.80-2.05 (4H, m), 2.85-3.20 (4H, 
m), 4.02 (3H, s), 4.06 (3H, s), 4.06-4.10 (1H, m), 4.11 (3H, s), 4.38 (1H, d, J = 16.2 Hz), 
7.20 (1H, s), 7.19-7.25 (2H, m), 7.91 (1H, d, J = 2.5 Hz), 7.93 (1H, s), 7.96 (1H, d, J = 
9.1 Hz); 13C NMR (68 MHz, CDCl3) δ 17.3, 20.2, 36.1, 39.4, 47.4, 50.9, 55.5, 55.9, 
56.0, 57.6, 103.1, 103.9, 104.7, 114.7, 123.2, 123.6, 125.0, 125.7, 125.8, 126.1, 130.5, 
148.2, 149.4, 157.5; HRMS calcd for C24H27NO3: 377.1991, found: 377.1987. 
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